This meta-analysis synthesizes data from 17 studies, demonstrating that serum PTX-3 levels are significantly higher in COPD patients compared to healthy controls, with even greater elevations observed in patients experiencing AECOPD. Here, PTX3 is linked to chronic obstructive pulmonary disease.